公开(公告)号：US20220249517A1

公开(公告)日：2022-08-11

申请号：US17478112

申请日：2021-09-17

Applicant: CLEARSIDE BIOMEDICAL, INC.

Inventor： Daniel WHITE ,  Glenn NORONHA ,  Jennifer KISSNER

IPC: A61K31/58 ,  A61K9/00 ,  A61P27/02 ,  A61M37/00 ,  A61K47/02 ,  A61K47/26 ,  A61K47/12 ,  A61K45/06 ,  A61K47/38

Abstract: The present invention relates to methods, devices, and compositions for treating ocular disorders such as uveitis, macular edema associated with uveitis, and diabetic macular edema. For example, the methods include treatment of subjects having macular edema associated with non-infectious uveitis, or diabetic macular edema, by administering to the subjects a triamcinolone composition via non-surgical administration to the suprachoroidal space (SCS) of the eye.

公开(公告)号：US20190269702A1

公开(公告)日：2019-09-05

申请号：US16292845

申请日：2019-03-05

Applicant: CLEARSIDE BIOMEDICAL, INC.

Inventor： Daniel WHITE ,  Glenn NORONHA ,  Jennifer KISSNER

IPC: A61K31/58 ,  A61K9/00 ,  A61P27/02 ,  A61M37/00

Abstract: The present invention relates to methods, devices, and compositions for treating ocular disorders such as uveitis, macular edema associated with uveitis, and diabetic macular edema. For example, the methods include treatment of subjects having macular edema associated with non-infectious uveitis, or diabetic macular edema, by administering to the subjects a triamcinolone composition via non-surgical administration to the suprachoroidal space (SCS) of the eye.